Supply Chain

The FDA on May 16 released a list of drug companies that may be using "gaming tactics" to delay generic competition from hitting the market.

Vermont Republican Gov. Phil Scott signed a bill May 16 to permit the importation of cheaper prescription drugs from Canada, reports Politico.

James Harrison, an 81-year-old Australian man, has donated his blood every few weeks for the past 60 years, helping save millions of newborns' lives, reports The New York Times.

Janssen Biotech and Pharmacyclics withdrew a proposed plan to introduce a new version of their blood cancer drug Imbruvica at triple the cost of the original, reports The Washington Post.

President Donald Trump presented his long-awaited "blueprint" to combat rising drug prices May 11, and despite previous remarks stating the pharmaceutical industry is "getting away with murder," Trump largely spares drugmakers from sweeping reform, according to The New York Times.

Amazon is making its move into healthcare by launching an exclusive line of 60 over-the-counter healthcare products and expanding its business-to-business marketplace to sell medical supplies to hospitals and clinics, and 62 percent of hospital leaders are supportive of the…

Most hospital operating rooms still rely on manual supply chain processes. And most clinicians and administrators aren’t too happy about it.

The FDA approved a pediatric indication for Novartis' multiple sclerosis drug Gilenya, the drugmaker announced May 11.

Boston Scientific is involved in tens of thousands of lawsuits filed by women who experienced health complications related to the devicemaker's gynecological mesh implants, according to a "60 Minutes" report aired May 13.

Here are the five latest drugs or medical devices approved by the FDA since April 27.